ARPA-H Awards $43M to Philadelphia Researchers to Advance Scalable Genetic Medicines for Rare Diseases
July 9, 2026 — The U.S. government has awarded $43 million to Philadelphia-based researchers through a new federal effort to advance scalable gene therapy and gene editing approaches for rare genetic…
Read the full articleYou might also wanna read
ARPA-H awards up to $160M to scientists developing custom genetic medicines
The Advanced Research Projects Agency for Health has awarded a new tranche of funds for companies and institutions developing personalized g
Jackson Laboratory and Broad Institute receive $34.5M ARPA-H award for pediatric epilepsy gene editing platform
Pediatric Epilepsies & Rare CNS Gene Editing Platform (PERC) accelerates the development of precision genetic medicines for severe childhood
jax.org·7d ago
STAT+: ARPA-H launches $160 million effort to develop custom gene editing drugs
An ARPA-H program to jump-start custom gene editing treatments was delayed by a change in administrations. Now seven labs will get sizable g
Profluent, GEMMABio, and ARPA-H ‘s 160 Million Base Editor Moonshot: Why the AI-Designed Editor Was Never the Bottleneck and the FDA’s Plausible Mechanism Pathway Is the Real Bet
ARPA-H just put $160M behind seven teams to advance personalized genetic medicines.
Georgia State, Columbia Researchers Lead Five-Year Study to Advance Treatment for Rare Eye Disease
New funding from the National Institutes of Health will support innovative therapeutic research to preserve sight.
High-cost gene therapies face financing barriers in US healthcare system
“We do not lack cures. We lack the infrastructure to pay for and deliver them,” writes William Padula.
statnews.com·1mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.